You just read:

Glenmark Pharmaceuticals Announces FDA Acceptance of the Company's First New Drug Application for Ryaltris™ for Patients with Seasonal Allergic Rhinitis

News provided by

Glenmark Pharmaceuticals

Aug 07, 2018, 10:00 ET